高危孕妇剖宫产预防产后出血应用欣母沛与米索前列醇的效果

张晓昱

陕西略阳县人民医院，陕西 汉中，724300

浏览次数：92次 下载次数：366次

摘要：

目的 探讨欣母沛与米索前列醇应用于行剖宫产术的高危孕妇以预防产后出血的效果。方法 选取在我院接受剖宫产术的 100例高危孕妇为研究对象，随机分为观察组与对照组，各 50例。在缩宫素的基础上，对照组采用米索前列醇，观察组采用欣母沛。比较两组产后出血及不良反应发生情况。结果 与对照组相比，观察组在产后 0.5、2、24 h的出血量明显更少，差异具有统计学意义（P＜0.05）；两组的不良反应总发生率比较，差异无统计学意义（P＞0.05）。结论 在行剖宫产术的高危孕妇术后出血的预防中，欣母沛的应用能够降低产妇产后出血量，效果优于米索前列醇，且不增加产妇的不良反应。

关键词： 欣母沛；米索前列醇；产后出血

中图分类号： R719.8文献标志码：A文章编号：2096-1413(2018)0苑-0132-02

Effect of hemabate and misoprostol in the prevention of postpartum hemorrhage in
high risk pregnant women undergoing cesarean section


ZHANG Xiao-yu
(the People`s Hospital of Lveyang County, Hanzhong 724300,China)



ABSTRACT: Objective To investigate the effect of hemabate and misoprostol in the prevention of postpartum hemorrhage in high risk pregnant women undergoing cesarean section. Methods One hundred high risk pregnant women undergoing cesarean section in our hospital were selected and randomly divided into observation group and control group, with 50 cases in each group.All the parturient were treated with oxytocin.Based on this,the control group was given misoprostol,and the observation group received hemabate.The postpartum hemorrhage and adverse reactionswere compared between the two groups. Results Compared with the control group,the amount of postpartum hemorrhage of the observation group at 0.5,2 and 24 hours after operation were moreless,the differences were statistically significant (P＜0.05). There was nosignificant difference in the total incidence of adverse reactions between the two groups (P＞0.05). Conclusion In the prevention of postpartum hemorrhage in high risk pregnant women undergoing cesarean section,hemabate can reduce the amount of postpartum hemorrhage,which has better clinical effect than misoprostol,and it doesn`t increase the adverse reactions of parturient.    

KEYWORDS: hemabate; misoprostol; postpartum hemorrhage

参考文献：
[1] 孙光彩 . 欣母沛与米索前列醇预防高危孕妇剖宫产术后产后出血的效果比较 [J]. 河南医学研究 ,2016,25(5):924-925.
[2] 王燕 . 欣母沛与米索前列醇用于预防剖宫产术高危孕妇产后出血分析 [J]. 中国医学工程 ,2014,22(4):46,50.
[3] 彭燕霞 . 欣母沛与米索前列醇预防高危孕妇剖宫产术后产后出血的效果比较 [J]. 中国现代医生 ,2013,51(19):56-57.
[4] 高俊 . 卡前列素氨丁三醇注射液 ( 欣母沛 ) 在子宫收缩乏力 ( 剖宫产术 ) 所致的产后出血中的应用 [J]. 医药前沿 ,2014,36(9):214-215.
[5] 平永美 , 郑江美 , 吴丽霞 . 两种方法对剖宫产术中出血量评估的比较及剖宫产术中出血的原因分析 [J]. 中国性科学 ,2015,24(4):87-90.
[6] 褚梅青 . 产后出血高危因素及预防措施的分析 [J]. 河南医学研究 ,2014,23(3):157-159.
[7] 陈逗 . 欣母沛联合米索前列醇预防高危产妇剖宫产后出血的疗效[J]. 实用临床医药杂志 ,2016,20(9):160-161.
[8] 马海蓉 .124 例产后出血原因及防治措施分析 [J]. 海南医学院学报 ,2012,18(1):93-94.
[9] 郑疆 , 陆莹 . 卡前列素氨丁三醇注射液和米索前列醇预防产后出血的临床对比分析 [J]. 中国计划生育学杂志 ,2015,23(1):48-50.
[10] 李毅 . 欣母沛预防高危孕妇产后出血的作用观察 [J]. 基层医学论坛 ,2013,17(35):4656-4657.
[11] 马秀杰 . 欣母沛联合米索前列醇在子宫收缩乏力产后出血中的应用 [J]. 中国医药指南 ,2016,14(20):174-175.
[12] 洪梅 . 宫缩乏力性产后出血应用欣母沛治疗的临床观察 [J]. 医学美学美容旬刊 ,2015,24(6):299-300.